HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Straczkowski, M. Articles by Gorski, J. Search for Related Content PubMed PubMed Citation Articles by Straczkowski, M. Articles by Gorski, J. Social Bookmarking                What's this?

Relationship Between Insulin Sensitivity and Sphingomyelin Signaling Pathway in Human Skeletal Muscle

¹ Department of Endocrinology, Diabetology and Internal Medicine, Medical University, Bialystok, Poland
² Department of Physiology, Medical University, Bialystok, Poland
³ Department of Applied Physiology, Polish Academy of Sciences, Warsaw, Poland

In vitro studies revealed that insulin resistance might be associated with the intracellular formation of ceramide, the second messenger in the sphingomyelin signaling pathway. The aim of the present study was to examine the content and composition of fatty acids in ceramide and sphingomyelin in human muscle and to evaluate their relationships with insulin sensitivity. The study was conducted on 27 male subjects with normal glucose tolerance. Euglycemic-hyperinsulinemic clamps and biopsies of vastus lateralis muscle were performed. In 10 subjects, additional biopsies were taken after a 4-h clamp and after a clamp with concurrent Intralipid/heparin infusion. We identified 13 ceramides and sphingomyelins according to fatty acid residues. Insulin sensitivity was related to total ceramide content (r = –0.49, P = 0.01) and to ceramide consisting of palmitic (r = –0.48, P = 0.011), palmitoleic (r = –0.45, P = 0.019), mirystic (r = –0.42, P = 0.028), and nervonic acid (r = –0.39, P = 0.047). Hyperinsulinemia did not affect estimated muscle parameters. Intralipid/heparin infusion resulted in a 24.73% decrease in insulin sensitivity (P = 0.007) and a 47.81% increase in ceramide content (P = 0.005). These changes were significantly related to each other (r = –0.64, P = 0.046). A relationship with the decrease in insulin sensitivity was also observed for ceramides consisting of palmitic (r = –0.68, P = 0.03) and linoleic (r = –0.66, P = 0.038) acid. Our data indicate that the sphingomyelin signaling pathway in muscle might be an important factor determining the development of insulin resistance in humans.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. R. Soeters, H. P. Sauerwein, J. E. Groener, J. M. Aerts, M. T. Ackermans, J. F. C. Glatz, E. Fliers, and M. J. Serlie Gender-Related Differences in the Metabolic Response to Fasting J. Clin. Endocrinol. Metab., September 1, 2007; 92(9): 3646 - 3652. [Abstract] [Full Text] [PDF]

				I. Kowalska, M. Straczkowski, A. Nikolajuk, A. Adamska, M. Karczewska-Kupczewska, E. Otziomek, S. Wolczynski, and M. Gorska Serum visfatin in relation to insulin resistance and markers of hyperandrogenism in lean and obese women with polycystic ovary syndrome Hum. Reprod., July 1, 2007; 22(7): 1824 - 1829. [Abstract] [Full Text] [PDF]

				A. C. Smith, K. L. Mullen, K. A. Junkin, J. Nickerson, A. Chabowski, A. Bonen, and D. J. Dyck Metformin and exercise reduce muscle FAT/CD36 and lipid accumulation and blunt the progression of high-fat diet-induced hyperglycemia Am J Physiol Endocrinol Metab, July 1, 2007; 293(1): E172 - E181. [Abstract] [Full Text] [PDF]

				L. Pickersgill, G. J. Litherland, A. S. Greenberg, M. Walker, and S. J. Yeaman Key Role for Ceramides in Mediating Insulin Resistance in Human Muscle Cells J. Biol. Chem., April 27, 2007; 282(17): 12583 - 12589. [Abstract] [Full Text] [PDF]

				M. J. Serlie, A. J. Meijer, J. E. Groener, M. Duran, E. Endert, E. Fliers, J. M. Aerts, and H. P. Sauerwein Short-Term Manipulation of Plasma Free Fatty Acids Does Not Change Skeletal Muscle Concentrations of Ceramide and Glucosylceramide in Lean and Overweight Subjects J. Clin. Endocrinol. Metab., April 1, 2007; 92(4): 1524 - 1529. [Abstract] [Full Text] [PDF]

				N. Ghosh, N. Patel, K. Jiang, J. E. Watson, J. Cheng, C. E. Chalfant, and D. R. Cooper Ceramide-Activated Protein Phosphatase Involvement in Insulin Resistance via Akt, Serine/Arginine-Rich Protein 40, and Ribonucleic Acid Splicing in L6 Skeletal Muscle Cells Endocrinology, March 1, 2007; 148(3): 1359 - 1366. [Abstract] [Full Text] [PDF]

				S. Mebarek, H. Komati, F. Naro, C. Zeiller, M. Alvisi, M. Lagarde, A.-F. Prigent, and G. Nemoz Inhibition of de novo ceramide synthesis upregulates phospholipase D and enhances myogenic differentiation J. Cell Sci., February 1, 2007; 120(3): 407 - 416. [Abstract] [Full Text] [PDF]

				M. J. Serlie, G. Allick, J. E. Groener, M. T. Ackermans, R. Heijligenberg, B. C. Voermans, J. M. Aerts, A. J. Meijer, and H. P. Sauerwein Chronic Treatment with Pioglitazone Does Not Protect Obese Patients with Diabetes Mellitus Type II from Free Fatty Acid-Induced Insulin Resistance J. Clin. Endocrinol. Metab., January 1, 2007; 92(1): 166 - 171. [Abstract] [Full Text] [PDF]

				T. E. Fox, X. Han, S. Kelly, A. H. Merrill Jr., R. E. Martin, R. E. Anderson, T. W. Gardner, and M. Kester Diabetes Alters Sphingolipid Metabolism in the Retina: A Potential Mechanism of Cell Death in Diabetic Retinopathy Diabetes, December 1, 2006; 55(12): 3573 - 3580. [Abstract] [Full Text] [PDF]

				S. M. Turpin, G. I. Lancaster, I. Darby, M. A. Febbraio, and M. J. Watt Apoptosis in skeletal muscle myotubes is induced by ceramides and is positively related to insulin resistance Am J Physiol Endocrinol Metab, December 1, 2006; 291(6): E1341 - E1350. [Abstract] [Full Text] [PDF]

				C. R. Bruce, A. B. Thrush, V. A. Mertz, V. Bezaire, A. Chabowski, G. J. F. Heigenhauser, and D. J. Dyck Endurance training in obese humans improves glucose tolerance and mitochondrial fatty acid oxidation and alters muscle lipid content Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E99 - E107. [Abstract] [Full Text] [PDF]

				J. S. Lee, S. K. Pinnamaneni, S. J. Eo, I. H. Cho, J. H. Pyo, C. K. Kim, A. J. Sinclair, M. A. Febbraio, and M. J. Watt Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites J Appl Physiol, May 1, 2006; 100(5): 1467 - 1474. [Abstract] [Full Text] [PDF]

				M. J. Watt, A. Hevener, G. I. Lancaster, and M. A. Febbraio Ciliary Neurotrophic Factor Prevents Acute Lipid-Induced Insulin Resistance by Attenuating Ceramide Accumulation and Phosphorylation of c-Jun N-Terminal Kinase in Peripheral Tissues Endocrinology, May 1, 2006; 147(5): 2077 - 2085. [Abstract] [Full Text] [PDF]

				M. Straczkowski, I. Kowalska, A. Nikolajuk, A. Krukowska, and M. Gorska Plasma Interleukin-10 Concentration Is Positively Related to Insulin Sensitivity in Young Healthy Individuals Diabetes Care, August 1, 2005; 28(8): 2036 - 2037. [Full Text] [PDF]

				J. A. Chavez, W. L. Holland, J. Bar, K. Sandhoff, and S. A. Summers Acid Ceramidase Overexpression Prevents the Inhibitory Effects of Saturated Fatty Acids on Insulin Signaling J. Biol. Chem., May 20, 2005; 280(20): 20148 - 20153. [Abstract] [Full Text] [PDF]

				S. A. Summers and D. H. Nelson A Role for Sphingolipids in Producing the Common Features of Type 2 Diabetes, Metabolic Syndrome X, and Cushing's Syndrome Diabetes, March 1, 2005; 54(3): 591 - 602. [Abstract] [Full Text] [PDF]

				A. Dobrzyn, P. Dobrzyn, S.-H. Lee, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, and J. M. Ntambi Stearoyl-CoA desaturase-1 deficiency reduces ceramide synthesis by downregulating serine palmitoyltransferase and increasing {beta}-oxidation in skeletal muscle Am J Physiol Endocrinol Metab, March 1, 2005; 288(3): E599 - E607. [Abstract] [Full Text] [PDF]

				S. J. Lessard, S. L. L. Giudice, W. Lau, J. J. Reid, N. Turner, M. A. Febbraio, J. A. Hawley, and M. J. Watt Rosiglitazone Enhances Glucose Tolerance by Mechanisms Other than Reduction of Fatty Acid Accumulation within Skeletal Muscle Endocrinology, December 1, 2004; 145(12): 5665 - 5670. [Abstract] [Full Text] [PDF]

				S. Stratford, K. L. Hoehn, F. Liu, and S. A. Summers Regulation of Insulin Action by Ceramide: DUAL MECHANISMS LINKING CERAMIDE ACCUMULATION TO THE INHIBITION OF Akt/PROTEIN KINASE B J. Biol. Chem., August 27, 2004; 279(35): 36608 - 36615. [Abstract] [Full Text] [PDF]